GL1X · GenesisL1 explorer

MolNFT v1 · #92534 · protein

HIV-1 protease (mutant Q7K L33I L63I) in complex with a bicyclic pyrrolidine inhibitor

4GB2 · Gag-pol polyprotein: “HIV-1 protease (mutant Q7K L33I L63I) in complex with a bicyclic pyrrolidine inhibitor”. X-ray diffraction, 2 ligands (0LQ, CL), 1 pocket (best druggability 0.75). MolNFT v1 #92534 on GenesisL1: 3D structure…

PDB
4GB2
Type
protein
Length
198 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Gag-pol polyprotein
EC
3.4.23.16, 2.7.7.49, 2.7.7.7, 3.1.26.13, 3.1.13.2
UniProt
P03367
Ligands
0LQ, CL
Pockets
1 · best druggability 0.75

Structure

x-ray diffraction · 1 distinct chain · 4% helix, 56% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BGag-pol polyprotein (EC 3.4.23.16, 2.7.7.49, 2.7.7.7, 3.1.26.13, 3.1.13.2)protein994% helix, 56% strandP03367

Ligands and binding sites

  • 0LQ · (4aS,7aS)-1,4-bis(diphenylmethyl)hexahydro-1H-pyrrolo[3,4-b]pyrazine-2,3-dione · ligand · chains A, B
  • CL · Chloride ion · ion · 3 copies · chains A, B
  • GOL · Glycerol · additive · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13610.750.86360LQ

Interfaces

1 interface between chains.

  • A–B · 1859 Ų buried · 40 hydrogen bonds · protein-protein

Compared structures

  • 4GB2 · HIV-1 protease (mutant Q7K L33I L63I) in complex with a bicyclic pyrrolidine inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.